Trademark Details For MIRACLE-GRO (Serial Number 72046856)

  •  Home
  •  Print
MIRACLE-GRO
  • Rank
    Global Trademark Influence Ranking
    3398
0
0
0
0
Serial Number  United States - USPTO 72046856
Registration Number 0668868
Mark
MIRACLE-GRO
Filing Date Feb-28-1958
Status
Registered  
REGISTERED A.. (800)
REGISTERED AND RENEWED
Attorney Name
TTAB149



  • Mark Literal Elements:

010Medical apparatus

U.S Class(es): 010

Class Status: Active

First Use: Apr-15-1951

First Use in Commerce: Apr-15-1951





Correspondences

NameRobert Morgan
AddressOMS Investments, Inc. 10250 Constellation Blvd., Suite 2800 Los Angeles CA 90067

Prosecution History

DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Jun-09-2021NOTICE OF SUIT   NOSUI
Jun-23-2020NOTICE OF SUIT   NOSUI
Jan-28-2020NOTICE OF SUIT   NOSUI
Oct-23-2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED   ARAAI
Oct-23-2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED   REAPI
Sep-26-2018NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED   NA89E
Sep-26-2018REGISTERED AND RENEWED (FOURTH RENEWAL - 10 YRS)   RNL4Q
Sep-26-2018REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED   89AGO
Sep-26-2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL   APREA
Sep-20-2018TEAS SECTION 8 & 9 RECEIVED   E89RI
Oct-28-2017COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED   REM2E
Jun-20-2016NOTICE OF SUIT   NOSUI
Jun-20-2016NOTICE OF SUIT   NOSUI
Aug-26-2013NOTICE OF SUIT   NOSUI
Jul-22-2010NOTICE OF SUIT   NOSUI
Jan-16-2009CASE FILE IN TICRS   CFITO
Jul-23-2008REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)   RNL3Q
Jul-23-2008REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED   89AGO
Jul-22-2008ASSIGNED TO PARALEGAL   PLGLA
Jul-10-2008TEAS SECTION 8 & 9 RECEIVED   E89RI
Jan-25-1999REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)   RNL2Q
Oct-28-1998REGISTERED - SEC. 9 FILED/CHECK RECORD FOR SEC. 8   9.AFI
Oct-28-1978REGISTERED AND RENEWED (FIRST RENEWAL - 20 YRS)   REN1R